Applied Therapeutics Inc (STU:2UV)
€ 9.415 0.23 (2.5%) Market Cap: 1.11 Bil Enterprise Value: 999.30 Mil PE Ratio: 0 PB Ratio: 16.27 GF Score: 39/100

Applied Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 16, 2023 / 07:20PM GMT
Release Date Price: €0.993 (+9.06%)
Joseph Schwartz
SVB Securities - Analyst

Hello, welcome to this presentation with Applied Therapeutics. I'm pleased to be joined by Shoshana Shendelman. She's the Founder and CEO of the company, who will be presenting an update, and then we'll have a few minutes for Q&A. Thanks so much for being with us, Shoshana.

Shoshana Shendelman
Applied Therapeutics, Inc. - CEO & Founder

Thanks, Joe. So I'll just give a quick overview to start on what we're doing in Applied Therapeutics, our business strategy, our pipeline, and then we can delve into some of the details. We did have a data readout just this morning, so it's great timing.

So we are developing drugs specifically for diseases that have no treatment options available, but where there's a very clear and well understood biology of disease, and where we have technological advancement that can allow us to move quickly through development. As you'll see, especially in the data today, we use biomarkers early on to make sure that the drugs are working the way that we think they are, ensure that we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot